Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03131713 · ClinicalTrials.gov registry record · Phase 3
Preoperative Acetaminophen and Carbohydrate Loading
A Phase 3 study of Non-Melanoma Skin Cancer, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT03131713 is a Phase 3 study of Non-Melanoma Skin Cancer that has completed, run by Tufts Medical Center. The registered enrollment target is 101 participants, above the 38-participant average among 5 other Non-Melanoma Skin Cancer trials with a reported enrollment target (166% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03131713, a Phase 3 study of Non-Melanoma Skin Cancer, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
The study's goal is to assess impact of preoperative acetaminophen and oral carbohydrate drinks on pain and functional status experienced by patients undergoing Mohs micrographic surgery for non-melanoma skin cancers. Patients are randomly assigned to receive standard of care or preoperative acetaminophen 1000 mg and Gatorade sports drinks 2 packets before surgery. Patients are then asked to rate their level of pain, anxiety, thirst, hunger, fatigue on a scale of 0-100 on day of surgery before surgery has started, after clearance of skin cancer, and at the end of the visit. Patients are contacted by phone 48 hours after their surgery to assess their maximum level of post-operative pain (rated from 0-100), usage of over the counter or prescribed pain medications, and presence of complications e.g. bleeding, infection, dehiscence. Differences in perioperative functional status and pain medication usage are compared between patients in control and intervention groups.
Conditions Studied
Interventions
- DRUG Acetaminophen
Study Locations (1)
Massachusetts
- Tufts Dermatology - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2017-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03131713
The ClinicalTrials.gov registry entry for NCT03131713 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 38-participant average among 5 other Non-Melanoma Skin Cancer trials with a reported enrollment target (166% higher). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Melanoma Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Acetaminophen is the first listed.
NCT03131713 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03131713 about?
NCT03131713 is a clinical study titled "Preoperative Acetaminophen and Carbohydrate Loading". The study's goal is to assess impact of preoperative acetaminophen and oral carbohydrate drinks on pain and functional status experienced by patients undergoing Mohs micrographic surgery for non-melanoma skin cancers. Patients are randomly assigned to receive standard of care or preoperative acetami...
What is the current status of trial NCT03131713?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2016-07-01. Estimated completion is 2017-12-31.
What conditions does trial NCT03131713 study?
This clinical trial studies the following conditions: Non-Melanoma Skin Cancer.
What interventions are being tested in trial NCT03131713?
The interventions under investigation include: Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT03131713?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03131713 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Melanoma Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
RECRUITING · NA
-
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
RECRUITING · NA
-
Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
COMPLETED
-
Dietary Prevention of Photodamage in Skin With Grapes
COMPLETED · NA
-
Can We Miss Pigmented Lesions in Psoriasis Patients?
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.